DHRS3 and thyroid gland papillary carcinoma: We demonstrated here that DHRS3 is negatively correlated with TNBC patients’ overall survival, which is consistent with the previous finding of frequent amplification of DHRS3 in the intermediate/high-risk group of papillary thyroid carcinomas [51], thus suggesting a potential oncogenic function of DHRS3.